SUPERNUS PHARMACEUTICALS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

SUPERNUS PHARMACEUTICALS, INC. reported Cash And Cash Equivalents At Carrying Value of $128.45 million for the year ending 2025.

  • SUPERNUS PHARMACEUTICALS, INC. showed an increase of +85.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from SUPERNUS PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
  • XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 17 years of available data (2009 to 2025), SUPERNUS PHARMACEUTICALS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 309.0%.
  • Historical annual values: Fiscal year 2025: $128.45 million | Fiscal year 2024: $69.33 million | Fiscal year 2023: $75.05 million | Fiscal year 2022: $93.12 million | Fiscal year 2021: $203.43 million | Fiscal year 2020: $288.64 million | Fiscal year 2019: $181.38 million | Fiscal year 2018: $192.25 million | Fiscal year 2017: $100.30 million | Fiscal year 2016: $66.40 million | Fiscal year 2015: $33.50 million | Fiscal year 2014: $36.40 million | Fiscal year 2013: $32.98 million | Fiscal year 2012: $40.30 million | Fiscal year 2011: $48.54 million | Fiscal year 2010: $23.74 million | Fiscal year 2009: $31.41 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: